TAH and BSO with adjuvant pelvic EXRT and vaginal Cs-137 boost in the management of carcinoma of the endometrium.
Combined surgery and radiation has become standard therapy for operable endometrial cancer patients with stage IA (grade 2-3 or deep muscle invasion), stage IB, stage II, and selected stage III disease. We discuss the rationale for whole pelvic external-beam radiation therapy (EXRT) followed by vaginal endocurietherapy (ECT) boost, and present the outcome of 43 patients with endometrial cancer treated by combined surgery and radiation.
Kumar
P P
PP
Faculty of the Division of Radiation Oncology, Department of Radiology, University of Nebraska College of Medicine, Omaha.
Good
R R
RR
Scott
J C
JC
McCaul
G F
GF
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D001918:Brachytherapy; D002588:Cesium Radioisotopes / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005187:Fallopian Tubes / Q000601:surgery*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D010052:Ovariectomy; D011882:Radiotherapy, High-Energy; D014594:Uterine Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*
D002588:Cesium Radioisotopes